Franz Ziel GmbH
Trending Articles
Related Content
Manufacturing
Cell and gene therapies: on the brink of commercialisation
With their one-and-done potential and pinpoint targeting capability, cell and gene therapies (CGTs) offer huge promise in the fight against a range of previously untreatable diseases. Yet, investment in this sector is not taken lightly. Typically, developers must invest billions of dollars in therapies that might take 10 years to reach the market as they battle the odds against high failure rates